Express Pharma

facebook
twitter
google_plus
Email

Browsing tag

XALKORI

Pfizer gets USFDA nod for XALKORI (crizotinib) to treat ALK-positive ALCL in children and young adults

Home
- Drug approvals
- Nutraceuticals
- Pharma IT
- Policies
- Technology
- Logistics
- HR
- Biotech
- Startup Corner
- Business Strategies
- AYUSH
- More
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads

View Desktop Version